Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: J Pain Symptom Manage. 2012 Jul 7;44(6):810–822. doi: 10.1016/j.jpainsymman.2011.12.281

Table 1.

Demographic and Clinical Characteristics by Treatment Group (N=86)

Intervention Waitlist Total
n = 43 n = 43 N=86
n (%) n (%) n (%)
Age, mean (SD) 60.44 (10.76) 60.14 (11.54) 60.29 (11.09)
Gender
 Male 14 (33%) 21 (49%) 35 (41%)
 Female 29 (67%) 22 (51%) 51 (59%)
Ethnicity
 Non-Hispanic / Latino 43 (100%) 43 (100%) 86 (100%)
Race
 White 41 (96%) 39 (91%) 80 (93%)
 Black 1 (2%) 3 (7%) 4 (5%)
 Asian 0 (0%) 1 (2%) 1 (1%)
 Native American / Alaskan Native 1 (2%) 0 (0%) 1 (1%)
Education
 < HS diploma 1 (2%) 2 (5%) 3 (4%)
 HS diploma / GED 8 (19%) 11 (26%) 19 (22%)
 Undergrad college 26 (60%) 23 (53%) 49 (57%)
 Graduate school 8 (19%) 7 (16%) 15 (17%)
Cancer Diagnosis
 Lung 10 (23%) 15 (35%) 25 (29%)
 Prostate 6 (14%) 9 (21%) 15 (17%)
 Colorectal 6 (14%) 4 (9%) 10 (12%)
 Gynecologic 21 (49%) 15 (35%) 36 (42%)
Current Treatment
 Chemotherapy 30 (70%) 32 (75%) 62 (72%)
 Radiation Therapy 9 (21%) 10 (23%) 19 (22%)
 Chemo + Radiation 4 (9%) 1 (2%) 5 (6%)
Concurrent Symptoms
 Nausea 20 (47%) 26 (60%) 46 (53%)
 Distress 34 (79%) 37 (86%) 71 (83%)
 Shortness of Breath 24 (56%) 28 (65%) 52 (60%)
 Trouble Remembering 33 (77%) 30 (70%) 63 (73%)
 Lack of appetite 28 (65%) 29 (67%) 57 (66%)
 Drowsiness 42 (98%) 40 (93%) 82 (95%)
 Dry Mouth 31 (72%) 33 (77%) 64 (74%)
 Sadness 27 (63%) 33 (77%) 60 (70%)
 Vomiting 4 (9%) 5 (12%) 9 (10%)
 Numbness 23 (53%) 25 (58%) 48 (56%)
Supportive Meds Ordered
 Opioids 25 (58%) 26 (61%) 51 (59%)
 Steroids 32 (74%) 29 (67%) 61 (71%)
 Psychostimulants 3 (7%) 2 (5%) 5 (6%)
 Hypnotics / Sedatives 17 (40%) 15 (35%) 32 (37%)
 Antidepressants 9 (21%) 5 (12%) 14 (16%)
 Antiemetics 37 (86%) 37 (86%) 74 (86%)
 Colony stim. factors 1 (2%) 3 (7%) 4 (5%)
 Other 24 (56%) 19 (44%) 43 (50%)